MedPath

KAZANO

These highlights do not include all the information needed to use KAZANO safely and effectively. See full prescribing information for KAZANO. KAZANO (alogliptin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 2013

Approved
Approval ID

83cb7914-a683-47bb-a713-f2bc6a596bd2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 7, 2023

Manufacturers
FDA

Takeda Pharmaceuticals America, Inc.

DUNS: 039997266

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

alogliptin and metformin hydrochloride

PRODUCT DETAILS

NDC Product Code64764-335
Application NumberNDA203414
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateJuly 31, 2023
Generic Namealogliptin and metformin hydrochloride

INGREDIENTS (11)

ALOGLIPTIN BENZOATEActive
Quantity: 12.5 mg in 1 1
Code: EEN99869SC
Classification: ACTIM
Metformin hydrochlorideActive
Quantity: 500 mg in 1 1
Code: 786Z46389E
Classification: ACTIB
mannitolInactive
Code: 3OWL53L36A
Classification: IACT
microcrystalline celluloseInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
talcInactive
Code: 7SEV7J4R1U
Classification: IACT
ferric oxide yellowInactive
Code: EX438O2MRT
Classification: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6
Classification: IACT
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MK
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT

alogliptin and metformin hydrochloride

PRODUCT DETAILS

NDC Product Code64764-337
Application NumberNDA203414
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateJuly 31, 2023
Generic Namealogliptin and metformin hydrochloride

INGREDIENTS (11)

ALOGLIPTIN BENZOATEActive
Quantity: 12.5 mg in 1 1
Code: EEN99869SC
Classification: ACTIM
Metformin hydrochlorideActive
Quantity: 1000 mg in 1 1
Code: 786Z46389E
Classification: ACTIB
mannitolInactive
Code: 3OWL53L36A
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
microcrystalline celluloseInactive
Code: OP1R32D61U
Classification: IACT
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MK
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
talcInactive
Code: 7SEV7J4R1U
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
ferric oxide yellowInactive
Code: EX438O2MRT
Classification: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KAZANO - FDA Drug Approval Details